Table 5.
Kindling parameters and effect of valproate in good and poor valproate responders
| Parameter | Poor responders | Good responders | p |
|---|---|---|---|
| Kindling development | |||
| Initial ADT (μA) | 190.6 ± 28.6 (110–590) | 159.1 ± 23.3 (90–330) | 0.2384 |
| Kindling rate (number of stimulations until stage V) | 7.4 ± 0.5 (5–12) | 7.7 ± 0.9 (5–12) | 0.8011 |
| Cumulative afterdischarge duration until stage V (sec) | 151.9 ± 12.2 (52–250) | 210.1 ± 28.3 (110–385) | 0.1747 |
| Effect of VPA on ADTs in kindled rats | |||
| Control ADT (μA) in fully kindled rats | 83.3 ± 8.3 (39–145) | 55.8 ± 6.7 (29–110)* | 0.0246 |
| VPA ADT (% of individual control ADT) | 123.3 ± 16.2 (25–233) | 394.8 ± 34.5 (245–640)*** | <0.0001 |
| VPA plasma level (μg/ml) | 383.7 ± 10.0 (320–461) | 380.5 ± 14.9 (303–441) | 0.7860 |
For comparison of kindling development and the effect of VPA on ADTs, the group of 27 kindled rats was divided into poor responders (individual ADT increase after 200 mg/kg VPA, i.p., below mean group increase of ADT of 234%; n = 16) and good responders (individual ADT increase >234%; n = 11). Good and poor responders did not differ in kindling development (Mann–Whitney U test). Good and poor responders significantly differed in the predrug (control) ADT determined after injection of saline and in the effect of VPA on ADTs (Student's t test; marked by asterisks). The average VPA concentration was about the same in good and poor responders (Mann–Whitney U test). Data are means ± SEM (range).